AI Investors Have Opportunity to Join C3.ai, Inc. Fraud Investigation with the Schall Law Firm 
RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements 
WL Delicious Announced 2025 Interim Results Bellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update
– Entered into a licensing agreement with two leading oncology research and treatment centers for…
Relay Therapeutics Announces Corporate Updates and Reports Second Quarter 2021 Financial Results
Company selected RLY-2608 as PI3Kα mutant inhibitor development candidate and plans to initiate first-in-human study…
Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
SEATTLE, Aug. 12, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
Bolt Biotherapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights
– BDC-1001 Phase 1/2 trial in HER2-expressing solid tumors on track for data update in…
4D Molecular Therapeutics Reports Financial Results for the Second Quarter of 2021 and Provides Operational Highlights
EMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage…
Nkarta Reports Second Quarter 2021 Financial Results and Business Progress
Initial data from NKX101 clinical trial expected by end of 2021 NKX019 patient dosing expected…
Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates
On track to report top-line interim data from ADI-001 Phase 1 study in Non-Hodgkin’s Lymphoma…
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
Received approval from Health Canada to initiate a clinical trial of AT-1501 in kidney transplantation;…
CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time BERKELEY HEIGHTS, N.J., Aug. 12,…
Myovant Sciences Appoints Uneek Mehra as Chief Financial and Business Officer
BASEL, Switzerland, Aug. 12, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company…
Brickell Biotech Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Final patient has completed the Phase 3 pivotal Cardigan I study; Enrollment completed in Phase…
Progenity Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Announced successful completion of the validation study PRO-104 for the Preecludia™ rule out test for preeclampsia…
TFF Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
Additional Data Readouts and Initiation of Pivotal Trials for Inhaled Tacrolimus and Voriconazole Programs Expected…
Tempest Reports Second Quarter 2021 Financial Results and Provides Corporate Highlights
Closed merger transaction resulting in public listing (TPST) Closed $30M PIPE, extending runway into Q1’23…
Seer Bio Partners with Enlight Medical to Commercialize the Proteograph™ Product Suite in China
REDWOOD CITY, Calif. and BEIJING, Aug. 12, 2021 (GLOBE NEWSWIRE) — Seer Inc. (NASDAQ: SEER),…
Capricor Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
CAP-1002 – Capricor’s Cell Therapy Program for Duchenne Muscular Dystrophy -Phase III Trial Protocol Submitted…
Greenrose Acquisition Corp. Announces Extension of Time to Consummate Business Combinations
AMITYVILLE, N.Y., Aug. 12, 2021 (GLOBE NEWSWIRE) — Greenrose Acquisition Corp. (OTC: GNRSU, GNRS, GNRSW)…
Salarius Pharmaceuticals to Present at the Virtual Diamond Equity Research Emerging Growth Invitational
HOUSTON, Aug. 12, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
InMed Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference
VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors
Ms. Crane brings over 30 years of experience in executive leadership, commercialization, and business development…